EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Are the SORG and OPTI model, Tokuhashi and Tomita Algorithms Still Suitable as Predictors of Survival in Patients With Vertebral Metastases in Routine Clinical Practice?

Julián Cabria Fernández iD, Pablo González-Herráez Fernández iD, Javier Mateo Negreira iD, Pedro Arcos González iD

Cancer Medicine · 2026

DOI: 10.1002/cam4.71520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Julián Cabria Fernández und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Traumatology, Cabueñes University Hospital, Gijón, Spain. Hauptthemen laut MEDLINE: Algorithms, Spinal Neoplasms, Machine Learning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the performance of the Tokuhashi, Tomita, SORG machine learning (SORG ML), and OPTImodel algorithms as survival predictors for vertebral metastases in clinical practice. Materials and Methods A retrospective study (2013–2023) analyzed 573 patients from Cabueñes University Hospital (Asturias, Spain). Thirty‐two demographic, epidemiological, clinical, and analytical variables were considered, including diagnosis chronology and survival.

Results

Among the 573 patients studied, 272 (47.4%) presented visceral metastases at the time of diagnosis. A total of 362 patients (63.2%) had associated comorbidities. The most frequent primary histological diagnoses in these patients were lung 147 (25.7%), prostate 146 (25.5%), breast 118 (20.6%), kidney 30 (5.2%), and colorectal 29 (5.1%). The median survival of the cohort was 185 days. The accuracy rates for the Tokuhashi, SORG ML, OPTImodel, and Tomita algorithms were 0.5509, 0.4812, 0.3404, and 0.3858, respectively. The models with the highest accuracy rates in specific time segments were Tokuhashi (77.5% for < 6 months) and OPTImodel (90.8% for more than 1 year). The areas under the curve (AUC) for survival intervals were as follows: Tokuhashi at 42 days (73.19%), 90 days (79.3%), and 365 days (82.73%); Tomita at 42 days (69.27%), 90 days (76.82%), and 365 days (78.79%); SORG ML at 42 days (52.77%), 90 days (51.69%), and 365 days (51.38%).

Conclusions

All models showed relatively low accuracy. The newer models (OPTImodel, SORG ML) did not outperform the traditional Tomita and Tokuhashi in predicting survival for vertebral metastases patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsSpinal NeoplasmsMachine LearningHumansFemaleMaleRetrospective StudiesMiddle AgedAgedPrognosisAged, 80 and overPrediction AlgorithmsAdultSpain

Autor:innen und Institutionen

  • Department of Orthopedic Surgery and Traumatology, Cabueñes University Hospital, Gijón, Spain.
  • Department of Medicine, University of Oviedo, Oviedo, Spain.

ORCID-Profile: Julián Cabria Fernández, Pablo González-Herráez Fernández, Javier Mateo Negreira, Pedro Arcos González

Zitieren

APA

Cabria Fernández, J., González-Herráez Fernández, P., Mateo Negreira, J., & Arcos González, P. (2026). Are the SORG and OPTI model, Tokuhashi and Tomita Algorithms Still Suitable as Predictors of Survival in Patients With Vertebral Metastases in Routine Clinical Practice?. Cancer Medicine. https://doi.org/10.1002/cam4.71520

Vancouver

Cabria Fernández J, González-Herráez Fernández P, Mateo Negreira J, Arcos González P. Are the SORG and OPTI model, Tokuhashi and Tomita Algorithms Still Suitable as Predictors of Survival in Patients With Vertebral Metastases in Routine Clinical Practice?. Cancer Medicine. 2026. doi:10.1002/cam4.71520

BibTeX
@article{CabriaFernndez2026,
  author = {Cabria Fernández, Julián and González-Herráez Fernández, Pablo and Mateo Negreira, Javier and Arcos González, Pedro},
  title = {Are the SORG and OPTI model, Tokuhashi and Tomita Algorithms Still Suitable as Predictors of Survival in Patients With Vertebral Metastases in Routine Clinical Practice?},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71520}
}
Kostenlos starten →